Literature DB >> 9540344

Histopathological features of pulmonary asbestosis with particular emphasis on the comparison with those of usual interstitial pneumonia.

S Yamamoto1.   

Abstract

We examined 40 autopsy cases of pulmonary asbestosis which were defined by occupational history, lung fibrosis and asbestos bodies (ABs) to clarify histopathological features. Thirty four patients were males and six were females. The mean age was 64.1 +/- 1.6. Gross findings of 39 cases (one case was examined only microscopically) showed that pleural adhesion in 31/39, visceral pleural thickening in 37/39, and pleural plaques in 26/33 except of 6 cases with severe adhesion. Four cases had no or only mild pleural adhesion or pleural thickening, and no pleural plaques. Grossly, lung fibrosis of asbestosis can be divided into two types of honeycombing (HNCB) predominant fibrosis (16 cases), and atelectatic induration predominant fibrosis (23 cases). Histologically, the honeycombing type fibrosis showed peripheral acinar fibrosis like in usual interstitial pneumonia (UIP), whereas the atelectatic induration type exhibited non-peripheral acinar fibrosis with intraluminal organization unlike in UIP. In our study, the lung fibrosis was more intensive in the lower lobes, posterior and subpleural zones, although in eight cases the upper lobes were more intensively involved than the lower lobes. The degree of asbestos body formation on each case was varied. Four cases with typical honeycombing and fibrosis grade 3 were counted only small numbers of asbestos bodies, and lacked one or two above-described pleural changes, and these cases were similar to idiopathic or usual interstitial pneumonia (UIP). As for complications of asbestosis, 13 cases (32.5%) had lung cancer and 14 cases (35%) presented diffuse alveolar damage (DAD) pathologically. It is concluded that asbestosis cases of honeycombing type without pleural changes can not be distinguished even from UIP, if asbestos bodies (ABs) were not found histologically. Therefore, great care needs to be taken in identifying them. We also have examined the quantitatave counts of asbestos bodies and asbestos fibers in ten cases. Acute exacerbation of UIP is a well recognized entity in Japan, similar condition may occur in pulmonary asbestosis.

Entities:  

Mesh:

Year:  1997        PMID: 9540344

Source DB:  PubMed          Journal:  Osaka City Med J        ISSN: 0030-6096


  7 in total

Review 1.  Asbestosis and environmental causes of usual interstitial pneumonia.

Authors:  Mridu Gulati; Carrie A Redlich
Journal:  Curr Opin Pulm Med       Date:  2015-03       Impact factor: 3.155

2.  Interstitial Lung Disease Associated with Connective Tissue Diseases.

Authors:  Ruben A Peredo; Vivek Mehta; Scott Beegle
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Asbestosis and other pulmonary fibrosis in asbestos-exposed workers: high-resolution CT features with pathological correlations.

Authors:  Hiroaki Arakawa; Takumi Kishimoto; Kazuto Ashizawa; Katsuya Kato; Kenzo Okamoto; Koichi Honma; Seiji Hayashi; Masanori Akira
Journal:  Eur Radiol       Date:  2015-09-03       Impact factor: 5.315

4.  Clinical, radiological, and pathological investigation of asbestosis.

Authors:  Takumi Kishimoto; Katsuya Kato; Hiroaki Arakawa; Kazuto Ashizawa; Kouki Inai; Yukio Takeshima
Journal:  Int J Environ Res Public Health       Date:  2011-03-22       Impact factor: 3.390

5.  Predictors of diagnosis and survival in idiopathic pulmonary fibrosis and connective tissue disease-related usual interstitial pneumonia.

Authors:  Teng Moua; Ana C Zamora Martinez; Misbah Baqir; Robert Vassallo; Andrew H Limper; Jay H Ryu
Journal:  Respir Res       Date:  2014-12-04

Review 6.  Imaging diagnosis of classical and new pneumoconiosis: predominant reticular HRCT pattern.

Authors:  Akira Masanori
Journal:  Insights Imaging       Date:  2021-03-10

7.  Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases.

Authors:  Johanna Salonen; Minna Purokivi; Risto Bloigu; Riitta Kaarteenaho
Journal:  BMJ Open Respir Res       Date:  2020-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.